| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |